Compliance Rate

Compliance Rate 36.36%
Compliant submissions 8
Incompliant submissions 14
Total trials 22

My Organizations' Clinical Trials

Showing 250 of 1641 entries
View as:

Mechanisms of Ultrasound Neuromodulation Effects in Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT06042517 Org: User:
Start: 09/30/23 End: 09/30/27 Due: 09/30/28

Audiovisual Interactive Games to Alleviate Pediatric Perioperative Anxiety

Phase: N/A Priority: Normal
NCT ID: NCT06111742 Org: User:
Start: 11/14/23 End: 02/12/24 Due: 02/12/25

Continuous Glucose Monitoring in Youth With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT02293577 Org: User:
Start: 11/30/14 End: 11/30/15 Due: 11/30/16

Pivotal Response Treatment for Infants At-Risk for Autism Spectrum Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01691066 Org: User:
Start: 09/30/12 End: 02/27/17 Due: 02/27/18

TAS-OX for Refractory Metastatic Colon Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02848079 Org: User:
Start: 10/31/16 End: 06/02/20 Due: 06/02/21

Mindfulness Based Stress Reduction for Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03296514 Org: User:
Start: 07/01/17 End: 10/05/18 Due: 10/05/19

ctDNA Guided Adjuvant Treatment With Elacestrant: TBCRC-068

Phase: N/A Priority: Normal
NCT ID: NCT06923527 Org: User:
Start: 06/30/25 End: 06/30/27 Due: 06/30/28

Testing and Development of a Sleep Training Mobile Health Application

Phase: N/A Priority: Normal
NCT ID: NCT02718196 Org: User:
Start: 07/31/20 End: 01/31/21 Due: 01/31/22

Dosing Study of Cranberry Capsules for the Prevention of Bacteriuria in Nursing Home Residents

Phase: N/A Priority: Normal
NCT ID: NCT01033383 Org: User:
Start: 12/31/09 End: 12/31/10 Due: 12/31/11

Cannabinoids, Neural Synchrony, and Information Processing

Phase: N/A Priority: Normal
NCT ID: NCT00708994 Org: User:
Start: 02/25/08 End: 12/03/12 Due: 12/03/13

Effects of Weight Loss on Hepatic and Muscle Lipid Content and on Insulin Sensitivity on Obese Adolescents With NAFLD

Phase: N/A Priority: Normal
NCT ID: NCT00585299 Org: User:
Start: 10/31/06 End: 09/30/10 Due: 09/30/11

Investigating Markers of Energy Metabolism in Pregnant Women With Insulin Resistance

Phase: N/A Priority: Normal
NCT ID: NCT02109094 Org: User:
Start: 02/28/14 End: 02/28/15 Due: 02/28/16

The Effects of Cannabidiol and ∆-9-THC in Humans

Phase: N/A Priority: Normal
NCT ID: NCT01180374 Org: User:
Start: 02/01/10 End: 10/06/14 Due: 10/06/15

The Stimulation To Induce Mothers Study

Phase: N/A Priority: Normal
NCT ID: NCT05079841 Org: User:
Start: 11/15/21 End: 03/31/29 Due: 03/31/30

A Phase IIa Multi-Center Study of 18F-FDG PET, Safety, and Tolerability of AZD0530 in Mild Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT02167256 Org: User:
Start: 12/31/14 End: 02/27/18 Due: 02/27/19

SV2A Density Cannabis Use Disorder

Phase: N/A Priority: Normal
NCT ID: NCT05472818 Org: User:
Start: 04/12/22 End: 05/31/32 Due: 05/31/33

Cannabinoid Augmentation of Fear Response in Humans

Phase: N/A Priority: Normal
NCT ID: NCT01665573 Org: User:
Start: 07/17/12 End: 10/16/15 Due: 10/16/16

Evaluating the Unmet Needs of Older Adults to Promote Functional Recovery After a Critical Illness

Phase: N/A Priority: Normal
NCT ID: NCT06006000 Org: User:
Start: 01/25/24 End: 10/31/28 Due: 10/31/29

Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access

Phase: N/A Priority: Normal
NCT ID: NCT06658067 Org: User:
Start: 11/12/24 End: 10/31/25 Due: 10/31/26

Transcranial Direct Current Stimulation and Extinction in Obsessive Compulsive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06834217 Org: User:
Start: 08/01/25 End: 08/01/29 Due: 08/01/30

Biliary Atresia Research Network Northeast

Phase: N/A Priority: Normal
NCT ID: NCT06184971 Org: User:
Start: 05/06/24 End: 12/31/25 Due: 12/31/26

Effects of Novel E-cigarette Constituents on Adults TCORS 3.0

Phase: N/A Priority: Normal
NCT ID: NCT05932745 Org: User:
Start: 06/20/25 End: 05/31/26 Due: 05/31/27

Functional Neuroimaging of Alcoholism Vulnerability: Probing Glutamate and Reward, Using the mGluR5 Inhibitor Mavoglurant

Phase: N/A Priority: Normal
NCT ID: NCT05203965 Org: User:
Start: 05/17/22 End: 07/31/26 Due: 07/31/27

Mechanisms of Diuretic Resistance in Heart Failure, Aim 2

Phase: N/A Priority: Normal
NCT ID: NCT05753059 Org: User:
Start: 08/10/23 End: 06/30/27 Due: 06/30/28

Pharmacological and Behavioral Treatment After Bariatric Surgery

Phase: N/A Priority: Normal
NCT ID: NCT05157698 Org: User:
Start: 01/13/22 End: 01/12/28 Due: 01/12/29